STAT5A and pachyonychia congenita: This work supports a critical role for hyperactive Jak2-Stat5 signaling loop in promoting resistance of PC to ENZ and the need of evaluating the efficacies of Jak2 inhibitors as second-line treatments in advanced PC when ENZ fails.